Trial Profile
A Double-blind, Randomised, Placebo-controlled Study in Elderly Subjects to Evaluate the Safety, Tolerability, Pharmacodynamic Effects and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in a 2 g Suppository
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Methoxamine (Primary)
- Indications Faecal incontinence
- Focus Pharmacodynamics
- Sponsors Norgine
- 21 May 2014 New trial record